
Volume 38 · Number 11
NOVEMBER 2008
Psychiatric Risk Factors for Suicide in the Alcohol-dependent Patient
By Kenneth R. Conner, PsyD, MPH; Michael S. McCloskey, PhD; Paul R. Duberstein, PhD
Suicide is a serious public health concern. In 2004, more than 32,000 individuals died by suicide in the United States, exceeding the number of deaths by homicide that year. This number represents only a small portion (about 5%) of suicide attempts, many of which result in hospitalization and/or disability. Overall, suicide is the 11th leading cause of death in the United States and is the second leading cause of death among young adults. Thus, the need for improved efforts at suicide prevention is clear. Effective suicide prevention requires risk-identification and intervention strategies specifically tailored to high-risk populations. A wealth of data indicates that individuals with alcohol dependence are such a population. A meta-analysis concluded that individuals with alcohol dependence identified through treatment venues are at 9.8 (9.0-10.7) times greater risk for suicide compared to the general population. Furthermore, U.S. national survey data shows that alcohol dependence confers 6.5 (3.6-11.5) times greater risk for attempted suicide compared to individuals without alcohol dependence. Unequivocally, suicide prevention efforts must focus on alcoholism.
ABOUT THE AUTHORS
Kenneth R. Conner, PsyD, MPH; and Paul R. Duberstein, PhD, are with the Center for the Study and Prevention of Suicide and Laboratory of Personality and Development, Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York. Michael S. McCloskey, PhD is with the Department of Psychiatry, University of Chicago.
Address correspondence to: Michael McCloskey, Department of Psychiatry, University of Chicago, 5841 S. Maryland Ave MC #3077, Chicago, IL 60637. mmcclosk@yoda.bsd.uchicago.edu.
Dr. Conner, Dr. Duberstein, and Dr. McCloskey have disclosed no relevant financial relationships.
The Role of Comorbidity in Severity and Outcome
Jan Fawcett, MD
Challenges in Comorbidity
Barbara J. Mason, PhD
Clinical Implications of Epidemiologic Data for Diagnosis and Treatment of Psychiatric Comorbidity
Sharon Samet, PhD;
Deborah Hasin, PhD
Diagnostic and Treatment Considerations: Bipolar Patients with Comorbid Substance Use Disorders
Ihsan Salloum, MD, MPH;
Antoine Douaihy, MD;
Lauren Williams, MD
Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations
Sudie E. Back, PhD;
Kathleen T. Brady, MD, PhD
Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations
Edward V. Nunes, MD;
Frances R. Levin, MD
